This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of therapeutic agents targeting neurological disorders. Its structure suggests potential activity as a modulator of neurotransmitter systems, making it a candidate for research in treating conditions such as Alzheimer's disease, Parkinson's disease, or other cognitive impairments. The presence of the carbazole moiety indicates possible interactions with biological targets like enzymes or receptors involved in neural signaling pathways. Additionally, its fluorinated component may enhance its bioavailability and stability, making it a promising lead compound for further pharmacological studies and drug development.